Multidisciplinary guidelines for patient management are constantly updated on diverse topics in the treatment of thyroid disorders. Innovations in diagnostic tests, therapies, and surgical technologies are significantly influencing patient care options.
This year’s conference will cover key topics such as molecular applications in thyroid neoplasia, practical management tips, advances in laboratory testing, and new technologies in thyroid surgery. Our goal is to enhance competence and clinical performance in managing both routine and complex thyroid disorders to improve patient outcomes.
This one-day course provides up-to-date reviews in the management of thyroid diseases, with a focus on advancements in thyroid cancer care. Attendees will engage with didactic lectures, panel discussions, and a special keynote presentation, with ample time for interactive audience participation. The course is recorded and uploaded to Google Drive for convenient access.
Who Should Attend?
This course is designed for a multidisciplinary audience, including physicians, physician assistants, nurses, residents, fellows, and other health care professionals in primary care as well as specialties such as endocrinology, surgery, pathology, genetics, immunology, and oncology.
Learning Objectives:
After completing this course, participants will be able to:
Summarize the updated ATA guidelines for classification, risk stratification, management, and indications for fine needle aspiration of thyroid nodules, and interpret their clinical practice implications.
Recognize key updates for thyroid cytology and thyroid neoplasm classification, describing their clinical practice implications.
Distinguish state-of-the-art laboratory tests for thyroid disease, including immunoassays and mass spectrometry, while discussing their analytical limitations and roles in evaluating thyroid disease.
Critically review the efficacy, side effects, and clinical indications for thyroid cancer therapies, both FDA-approved and those in development.
Summarize the efficacy and safety profiles of targeted therapies for thyroid cancer, describing current research in targeted drug development and combination therapies.
Identify molecular signatures associated with specific thyroid malignancies.
Describe the pathophysiology of thyroid eye disease and recognize the role of endocrinologists in the assessment, diagnosis, and medical management of this condition.
Recognize different surgical options and modalities in treating patients with various types of thyroid disorders and stages of thyroid cancer.
2 reviews for Cleveland Clinic Thyroid Expo 2024